Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 316,790Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Amgen Inc

02 2Amneal Pharmaceuticals

03 2Apotex Inc

04 2BIOSIMILAR COLLABORATIONS IRELAND LIMITED

05 2Bio-Thera Solutions

06 2CELLTRION INC.

07 2Celltrion

08 2CinnaGen Co

09 4Cipla

10 6F. Hoffmann-La Roche

11 2Genentech

12 4Pfizer Inc

13 2Samsung Bioepis

14 4Sandoz B2B

15 4Viatris

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB-AWWB

Brand Name : MVASI

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 100MG/4ML (25MG/ML)

Packaging :

Approval Date :

Application Number : 761028

Regulatory Info :

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB-AWWB

Brand Name : MVASI

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 400MG/16ML (25MG/ML)

Packaging :

Approval Date :

Application Number : 761028

Regulatory Info :

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB-MALY

Brand Name : ALYMSYS

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/4ML(25MG/ML

Packaging :

Approval Date :

Application Number : 761231

Regulatory Info :

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB-MALY

Brand Name : ALYMSYS

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 400MG/16ML(25MG/ML

Packaging :

Approval Date :

Application Number : 761231

Regulatory Info :

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB-TNJN

Brand Name : AVZIVI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/4ML(25MG/ML)

Packaging :

Approval Date :

Application Number : 761198

Regulatory Info :

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB-TNJN

Brand Name : AVZIVI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 400MG/16ML(25MG/ML)

Packaging :

Approval Date :

Application Number : 761198

Regulatory Info :

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB-ADCD

Brand Name : VEGZELMA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/4ML(25MG/ML)

Packaging :

Approval Date :

Application Number : 761268

Regulatory Info :

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB-ADCD

Brand Name : VEGZELMA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 400MG/16ML(25MG/ML)

Packaging :

Approval Date :

Application Number : 761268

Regulatory Info :

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Bevacizumab

Brand Name : Stivant

Dosage Form : Injectable

Dosage Strength : 100MG

Packaging : Vial

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Bevacizumab

Brand Name : Stivant

Dosage Form : Injectable

Dosage Strength : 400MG

Packaging : Vial

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

bevacizumab

Brand Name : Avastin

Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage Strength : 25 MG / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Bevacizumab

Brand Name : Avastin

Dosage Form : Bevacizumab 100Mg 4Ml 1 Units Parenteral Use

Dosage Strength : 1 vial EV 100 mg 4 ml 25 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Bevacizumab

Brand Name : Avastin

Dosage Form : Bevacizumab 400Mg 16Ml 1 Units Parenteral Use

Dosage Strength : 1 vial EV 400 mg 16 ml 25 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : AVASTIN

Dosage Form : SOLUTION

Dosage Strength : 25MG/ML

Packaging : 4ML/16ML

Approval Date :

Application Number : 2270994

Regulatory Info : Prescription

Registration Country : Canada

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : AVASTIN

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 125085

Regulatory Info :

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : AVASTIN

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number : 125085

Regulatory Info :

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB-BVZR

Brand Name : ZIRABEV

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/4ML

Packaging :

Approval Date :

Application Number : 761099

Regulatory Info :

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB-BVZR

Brand Name : ZIRABEV

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 400MG/16ML

Packaging :

Approval Date :

Application Number : 761099

Regulatory Info :

Registration Country : USA

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : ZIRABEV

Dosage Form : SOLUTION

Dosage Strength : 100MG/4ML

Packaging :

Approval Date :

Application Number : 2489430

Regulatory Info : Prescription

Registration Country : Canada

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : ZIRABEV

Dosage Form : SOLUTION

Dosage Strength : 400MG/16ML

Packaging :

Approval Date :

Application Number : 2489449

Regulatory Info : Prescription

Registration Country : Canada

blank